Market Overview

UPDATE: ISI Group Upgrades Allscripts Healthcare Solution to Overweight on Possible Buyout

Related MDRX
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program
Allscripts Partners With CoverMyMeds to Help Patients Fill Prescriptions Faster

ISI Group raised its rating on Allscripts Healthcare Solution (NASDAQ: MDRX) from Market-weight to Overweight and increased its price target to $14.50.

ISI Group noted, "Late Friday, Bloomberg released a story that Allscripts is exploring a sale of the company and is in talks with private equity about a potential buyout. According to an unnamed source (“someone familiar with the matter”) MDRX has been in talks with several private equity firms and MDRX has hired advisors for a potential sale. Also according to the source, MDRX still may not sell the business. Based on this release, with a 50% probability for a deal (with an LBO valuation of $16.50) and a standalone base valuation of $12.50 (~13x FY13 P/E), we have upgraded shares to Overweight and increased our PT to $14.50."

Allscripts Healthcare Solutions closed at $12.42 on Friday.

Latest Ratings for MDRX

Aug 2015Argus ResearchUpgradesHoldBuy
Jun 2015OppenheimerInitiates Coverage onPerform
Apr 2015Piper JaffrayUpgradesUnderweightNeutral

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings


Related Articles (MDRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters